A kidney infection, also known as pyelonephritis, is a type of urinary tract infection, wherein one or both kidneys are infected. The infection is caused by bacteria or a virus that commonly begins to infect urinary bladder and moves up to one or both the kidneys. Signs or symptoms of pyelonephritis can vary depending on age and could include confusion & back pain, chills & high fever, nausea & vomiting, back, side, and groin pain, and painful urination. Predisposing factors of pyelonephritis include kidney stones, weakened immune system, structural problems of the urinary tract, urine reflux problems, and damage to nerves around the bladder.
The global pyelonephritis treatment market is projected to witness strong growth during the forecast period due to high prevalence and incidence rates of pyelonephritis disorder across the globe. Around 200,000 hospitalizations for acute pyelonephritis are reported in the U.S. each year. Hence, a large population base with kidney infection across the globe is expected to drive the global pyelonephritis treatment market during the forecast period. High per capita health care expenditure in developed countries, availability of technologically advanced hemodialysis systems, and favorable medical reimbursement in developed countries are anticipated to boost the pyelonephritis treatment market during the forecast period. Moreover, rise in demand for kidney care centers in countries such as India, China, Brazil, and South Korea is expected to drive the global pyelonephritis treatment market.
The global pyelonephritis treatment market can be segmented based on treatment algorithm and region. In terms of treatment algorithm, the pyelonephritis treatment market can be classified into initial pyelonephritis, acute pyelonephritis, and ongoing pyelonephritis. The pipeline of drugs for nephrotic syndrome is relatively small, with around 15 products in active development at public and private research centers and industries. Antibiotics is the initial treatment for pyelonephritis. Several new antibiotics are expected to be launched during the forecast period. These novel drugs will not only provide additional treatment options, especially for pyelonephritis treatment, but also drive market size, as these products will have higher price points than the generic products currently dominating the pyelonephritis treatment market. High prevalence of antibiotic resistance, particularly of strains with resistance, will drive pyelonephritis treatment market size, as treatment options for those infections will include non-generic antibiotics. Companies are presenting their pipeline molecule results in their annual meetings and conferences. In May 2018, Melinta Therapeutics highlighted Vabomere at making a difference in infectious diseases (MAD-ID) 2018 Annual Meeting. In August 2018, Entasis Therapeutics announced a positive topline results from phase II of ETX2514SUL in patients with complicated urinary tract infections including acute pyelonephritis.
In terms of region, North America dominated the global pyelonephritis treatment market in 2017. The market in the region is primarily powered by the U.S., which has witnessed highest incidence of the disease. State-of-the-art health care facilities that offer latest and the best treatment, high per capita health care spending among people, and awareness about available treatments for pyelonephritis augment the market in the region. Europe is another key market for pyelonephritis treatment. Germany and the U.K. are the major markets in the region. Greater degree of awareness with respect to overall kidney health has led to a large number of people undergoing screening for kidney diseases. Emerging economies such as India and China are the key markets for pyelonephritis treatment in Asia Pacific. Rise in population contributed to the growth of the pyelonephritis treatment market in the region.
Major players having pyelonephritis treatment products in the pipeline are Merck & Co, Inc., Wockhardt Ltd., AstraZeneca plc, Entasis Therapeutics, Inc., Iterum Therapeutics plc, Meiji Seika Pharma Co. Ltd., Paratek Pharmaceuticals, Inc., Nabriva Therapeutics plc, MerLion Pharmaceuticals Pte. Ltd., and Melinta Therapeutics, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.